Organoid Sciences is dedicated to developing next-generation regenerative cell therapies by leveraging organoids that contain a high concentration of organ-specific adult stem cells, offering exceptional regenerative capabilities when transplanted into damaged tissues. Additionally, organoids derived from patient tissues closely mimic human physiology, serving as a platform for new drug development and the discovery of novel substances.

"Organoid-Based Regenerative Therapies: Developing advanced regenerative treatments utilizing organoids rich in organ-specific adult stem cells, aiming to restore damaged tissues effectively. Organoid Drug Development Platform: Creating platforms that use patient-derived organoids to closely mimic human organs, facilitating the discovery and development of new drugs."

Private

Biotech